Physician profile
Matthew C Hsia
NPI 1841672268
$2,274.14
in general payments reported to CMS, 2019-2025
19 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.15 · 2020: $122 · 2022: $331 · 2023: $1,024 · 2024: $466 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,452 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,452.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $341.26 | 2023-2024 | Miebo, Xiidra, Vyzulta |
| Visionary Optics LLC | $319.96 | 2023 | |
| Coopervision INC. | $310.78 | 2023 | Misight Contact Lens, Onefit Contact Lens |
| Sun Pharmaceutical Industries INC. | $301.03 | 2019-2025 | Cequa |
| Amgen INC. | $124.26 | 2025 | Tepezza |
| Horizon Therapeutics Plc | $124.08 | 2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $115.16 | 2019-2023 | |
| Harrow Eye, LLC | $106.24 | 2024-2025 | Vevye |
| Johnson & Johnson Vision Care, INC. | $103.12 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $93.58 | 2024 | |
| Alcon Vision LLC | $52.13 | 2022 | |
| Eyevance Pharmaceuticals LLC | $52.06 | 2022 | |
| Abbvie INC. | $46.33 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $43.26 | 2019-2022 | |
| Glaukos Corporation | $41.82 | 2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $41.78 | 2022 | |
| Ani Pharmaceuticals, INC. | $28.95 | 2025 | Purified Cortrophin Gel |
| Sight Sciences, INC. | $15.29 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $13.05 | 2023 | Eylea |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hsia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.